[1] FOX M, VAN B V, BOUSAMRA M, et al. Surgical management of pulmonary carcinoid tumors: sublobar resection versus lobectomy[J]. Am J Surg, 2013, 205(2): 200-208.
[2] AYDIN E, YAZICI U, GULGOSTEREN M, et al. Long-term outcomes and prognostic factors of patients with surgically treated pulmonary carcinoid: our institutional experience with 104 patients[J]. Eur J Cardiothorac Surg, 2011, 39(4): 549-554.
[3] SHAN R, SABABATHAN S, MEARNS J, et al. Carcinoid tumour of the lung[J]. J Cardiovasc Surg, 1997, 38: 187-189.
[4] NAALSUND A, ROSTAD H, STROM EH, et al. Carcinoid lung tumors-incidence, treatment and outcomes: a population-based study[J]. Eur J Cardiothorac Surg, 2011, 39(4): 565-569.
[5] ZHONG C X, YAO F, ZHAO H, et al. Long-term outcomes of surgical treatment for pulmonary carcinoid tumors: 20 years' experience with 131 patients[J]. Chin Med J, 2012, 125(17): 3022-3026.
[6] MEZZETTI M, RAVEGLIA F, PANIGALLI T, et al. Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification[J]. Ann Thorac Surg, 2003, 76(6): 342-344.
[7] 王妍敏, 韩锋锋, 皮卫峰, 等. 支气管类癌的临床及影像学特点分析(附1例报告)[J]. 临床误诊误治, 2013, 26(7): 88-90.
[8] GARCIA-YUSTE M, MATILLA JM, CUETO A, et al. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric study of neur oendocrine tumours of the lung[J]. Eur Cardiothorac Surg, 2007, 31(2): 192-197.
[9] GUSTAFSSON BI, KIDD M, CHAN A, et al. Bronchopulmonary neuroendocrine tumors[J]. Cancer, 2003, 97(4): 934-959.
|